好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Modified Ordered Peptides for the Treatment of Multiple Sclerosis
010
Authors/Disclosures
David P. Roeltgen, MD, FAAN (Cape Regional Physicians Associates) No disclosure on file
No disclosure on file
Stefania Maraka, MD Dr. Maraka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Springworks Therapeutics. Dr. Maraka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Maraka has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Springworks Therapeutics. Dr. Maraka has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SpringWorks Therapeutics . The institution of an immediate family member of Dr. Maraka has received research support from Baxter.
Monica E. Loghin, MD (UT MD ANderson Cancer Center) Dr. Loghin has nothing to disclose.
Monica E. Loghin, MD (UT MD ANderson Cancer Center) Dr. Loghin has nothing to disclose.
No disclosure on file
No disclosure on file
Jayawant N. Mandrekar, PhD Dr. Mandrekar has nothing to disclose.
No disclosure on file
No disclosure on file
Stephen C. Cannon, MD (UT Southwestern Medical Center) No disclosure on file